National Center for Advancing Translational Sciences: Breaking Down Prednisone Too Quickly May Short-Circuit Its Benefit for Rare Neuromuscular Disorder
February 16, 2024
February 16, 2024
BETHESDA, Maryland, Feb. 16 (TNSres) -- The U.S. Department of Health and Human Services' National Center for Advancing Translational Sciences issued the following news release on Feb. 15, 2024:
Myasthenia gravis is a rare disorder of the nervous system and muscles that affects the immune system. For most people with myasthenia gravis, prednisone -- a steroid used to reduce inflammation (corticosteroid) -- can be an effective treatment. But for more than 20% of patients, predni . . .
Myasthenia gravis is a rare disorder of the nervous system and muscles that affects the immune system. For most people with myasthenia gravis, prednisone -- a steroid used to reduce inflammation (corticosteroid) -- can be an effective treatment. But for more than 20% of patients, predni . . .